Skip to content
Lower risk Drug recall · FDA · Published June 16, 2025

Sun Pharmaceuticals Recalls Lisdexamfetamine Capsules Due to Dissolution Test Failure

Sun Pharmaceuticals recalls 60mg lisdexamfetamine capsules (NDC 57664-051-88) due to failed dissolution tests at 9 months. This may affect drug stability and safety.

🇺🇸 FDA recall #D-0516-2025DrugSun Pharmaceuticals ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sun Pharmaceuticals is recalling 60mg lisdexamfetamine dimesylate capsules (100-count bottles) because lab tests showed the medication didn't dissolve properly after 9 months. This could mean the drug isn't working as intended or may be unsafe for patients. Read more at govinfonow.com/recall/32025-sun-pharmaceuticals-recalls-lisdexamfetamine-capsules-due-to-dissolution-test-failure.

Source Summary by GovInfoNow · govinfonow.com/recall/32025-sun-pharmaceuticals-recalls-lisdexamfetamine-capsules-due-to-dissolution-test-failure · Updated August 17, 2026 · FDA enforcement record: FDA #D-0516-2025

Cite this page

“Sun Pharmaceuticals Recalls Lisdexamfetamine Capsules Due to Dissolution Test Failure.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32025-sun-pharmaceuticals-recalls-lisdexamfetamine-capsules-due-to-dissolution-test-failure. Based on FDA recall #D-0516-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0516-2025%22&limit=1).

Why it’s dangerous

The capsules failed dissolution tests after 9 months of storage at 25°C and 60% humidity. This means the medication might not release the active ingredient properly when taken, potentially affecting its effectiveness or safety.

Who’s affected

People with prescriptions for lisdexamfetamine dimesylate capsules (60mg, 100-count bottles) from Sun Pharmaceuticals. Those who have the specific lot number AD42648 are most at risk.

How to tell if you have this one

Check for the product name 'Lisdexamfetamine Dimesylate Capsules, 60 mg', 100-count bottles, and lot number AD42648. The expiration date is February 28, 2026.

  • Brand
    Sun Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number AD42648 on the packaging to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Jun 16, 202512. FDA classified it Class II: Jul 11, 202523. Published in FDA’s Enforcement Report: Jul 23, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How can I confirm if my product is recalled?

Look for the lot number AD42648 on the packaging. The product was manufactured by OHM Laboratories in New Brunswick, NJ.

Similar recalls

Other Sun Pharmaceuticals recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0516-2025 (June 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0516-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA